Indications
Reduction of elevated intraocular pressure (IOP) in adult patients with primary open-angle glaucoma or ocular hypertension.
Composition
- Active substance
- netarsudil
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Rhokiinsa
- Active substance
- netarsudil
- ATC code
- S01EX05
- Group
- Sensory organs
- Therapeutic area
- Glaucoma, Open-Angle, Ocular Hypertension
- Marketing authorisation holder
- Santen Oy
- Status
- Authorised
- EU authorisation
- 19 Nov 2019
- EMA product number